サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1794405

キナーゼスクリーニングおよびプロファイリングサービスの世界市場

Kinase Screening and Profiling Services

出版日
ページ情報
英文 273 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
キナーゼスクリーニングおよびプロファイリングサービスの世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 273 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

キナーゼスクリーニングおよびプロファイリングサービスの世界市場は2030年までに4億3,610万米ドルに達する見込み

2024年に3億5,740万米ドルと推定されるキナーゼスクリーニングおよびプロファイリングサービスの世界市場は、2030年には4億3,610万米ドルに達すると予測され、分析期間2024-2030年のCAGRは3.4%で成長すると予測されます。本レポートで分析したセグメントの1つである放射性同位体は、CAGR 2.7％を記録し、分析期間終了時には2億9,090万米ドルに達すると予測されています。均質非放射性同位体セグメントの成長率は、分析期間中CAGR 4.7%と推定されます。

米国市場は9,740万米ドルと推定、中国はCAGR6.2％で成長予測

米国のキナーゼスクリーニングおよびプロファイリングサービス市場は、2024年に9,740万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8,600万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.4％と2.6％と予測されています。欧州では、ドイツがCAGR 1.9%で成長すると予測されています。

世界のキナーゼスクリーニングおよびプロファイリングサービス市場- 主要動向と促進要因のまとめ

なぜキナーゼスクリーニングおよびプロファイリングサービスは創薬で勢いを増しているのか？

キナーゼスクリーニングおよびプロファイリングサービスは、特に腫瘍学、炎症、代謝性疾患、神経変性疾患の分野において、現代の創薬の要となっています。キナーゼは、シグナル伝達や細胞調節に関与する酵素の大きなファミリーであり、細胞内情報伝達、成長、アポトーシスにおいて中心的な役割を担っているため、治療介入のための重要な標的です。キナーゼ活性の調節異常は広範な疾患に関与しており、特にがんでは特定のキナーゼが腫瘍の進行や治療抵抗性の促進因子として働いています。製薬企業やバイオテクノロジー企業が標的治療薬の開発にしのぎを削る中、キナーゼプロファイリングによって研究者は開発パイプラインの初期段階で化合物の選択性、オフターゲット効果、潜在的毒性を評価することができます。ハイスループットスクリーニングプラットフォームと広範なキナーゼパネルの組み合わせにより、何百ものキナーゼターゲットに対して何千もの化合物の迅速な評価が可能となり、医薬品化学戦略に情報を提供する豊富なデータセットが生成されます。このようなサービスに対する需要は、キナーゼに起因する変異を同定し、それに応じて薬物レジメンを調整することで、治療成績を大幅に改善できる個別化医療の台頭とともに高まっています。学術研究機関もまた、新規キナーゼターゲットを検証し、さらなる開発のための潜在的リード化合物を同定するために、商業サービスプロバイダーと協力することで、この勢いに貢献しています。キナーゼに特化した医薬品パイプラインの成長と研究中のキナーゼ阻害剤の増加は、アッセイ開発、選択性プロファイリング、メカニズム研究を提供するサービスプロバイダーにとって好都合な環境を作り出しています。このような活動の急増は、キナーゼ研究を支えるアッセイフォーマット、検出技術、バイオインフォマティクスツールの絶え間ない革新に拍車をかけ、これらのサービスを競争力のある創薬ワークフローの加速に不可欠なものにしています。

テクノロジーはキナーゼプロファイリングの範囲と精度をどのように高めているか？

技術の進歩は、キナーゼプロファイリングの範囲、精度、スピードを根本的に変え、製薬研究においてこれまで以上に不可欠なものとなっています。従来の低スループット法は、ハイスループットスクリーニング、質量分析ベースのプロテオミクス、複雑なアッセイ設定を効率的に処理する自動化ロボットを統合した次世代プラットフォームに取って代わられました。これらのツールは、様々な条件下で何百ものキナーゼを同時に評価する能力を研究者に提供し、キノーム全体にわたる化合物の挙動を包括的に理解することを可能にします。蛍光偏光、時間分解FRET、酵素結合検出技術の革新により、アッセイ感度が向上し、シグナル干渉が減少したため、活性ターゲットと不活性ターゲットの区別が容易になりました。さらに、細胞ベースのキナーゼアッセイの進歩により、生理学的に適切なモデルで化合物を研究する能力が向上し、単離された酵素系では見逃される可能性のある効果を捉えることができるようになりました。計算モデリングと人工知能の統合は、結合親和性を予測し、阻害剤相互作用をモデル化し、ヒットからリードへのワークフローを最適化することによって、キナーゼ研究に新たな次元を加えています。リアルタイムの実験結果を豊富に含むオープンアクセスのキナーゼデータベースは、研究者が新規化合物を既知のプロファイルに照らし合わせてベンチマークを行い、新規の選択性シグネチャーを発見することをさらに可能にしています。サービスプロバイダーは、クラウドベースのデータプラットフォームを活用し、インタラクティブなダッシュボード、リアルタイム分析、安全なデータ共有を顧客に提供し、コラボレーションと意思決定を強化しています。カスタマイズ可能なアッセイパネル、標的特異的プロファイリングキット、マルチプレックススクリーニングオプションは、治療領域全体にわたってこれらのサービスの有用性を拡大しています。これらの技術的改良は、開発期間とコストを短縮するだけでなく、キナーゼ標的治療薬の成功率を高め、イノベーションと創薬の強力な相乗効果を実証しています。

サービスプロバイダーに影響を与える市場勢力と戦略的提携とは？

市場情勢は、業界の需要、共同研究モデル、進化する規制状況のダイナミックな相互作用によって形成されています。バイオ医薬品企業が精密医療や標的療法にシフトする中、化合物の最適化を加速させる高品質で再現性のあるデータを提供する探索研究のアウトソーシングサービスへの依存度が高まっています。このため、初期スクリーニングから詳細なメカニズム研究に至るまで、エンドツーエンドのキナーゼアッセイプラットフォームを提供できる開発業務受託機関（CRO）や専門サービスプロバイダーに対する需要が急増しています。多くの企業が、キナーゼ阻害剤の共同開発、研究インフラの共有、研究開発パイプラインの合理化のために、学術機関やバイオテクノロジー企業と戦略的パートナーシップを結んだり、長期的提携を結んだりしています。特に希少がんや神経変性疾患のようなアンメットメディカルニーズのある分野では、官民のイニシアチブもキナーゼ研究を促進しています。キナーゼに特化したパイプラインを持つアーリーステージのバイオテクノロジー企業に対するベンチャーキャピタルからの資金提供は、費用対効果の高いハイスループット機能を提供する外部プロファイリングサービスへの需要をさらに刺激しています。さらに、医薬品開発の世界化により、北米、欧州、アジア太平洋全域の顧客に対応するサービスプロバイダーの範囲が広がっています。FDAやEMAなどの規制機関は、治験薬（IND）申請における選択性データとメカニズム検証の重要性を強化しており、企業は開発初期に厳格なキナーゼプロファイリングに投資するよう促しています。サービスプロバイダーは、品質保証プロトコルを強化し、規制に準拠したインフラに投資し、フォローオンバリデーション研究を含むサービスポートフォリオを拡大することで対応しています。このような市場勢力の収束により、キナーゼスクリーニングとプロファイリングは、技術的サービスとしてだけでなく、技術革新と規制上の成功の重要なイネーブラーとしての戦略的価値が強化されつつあります。

世界のキナーゼスクリーニングおよびプロファイリングサービス市場の成長を牽引するものは何か？

世界のキナーゼスクリーニングおよびプロファイリングサービス市場の成長は、医薬品開発戦略、技術進化、研究優先順位の変化に根ざした、相互に関連するいくつかの要因によって牽引されています。精密治療への注目が高まるにつれ、選択的で強力なキナーゼ阻害剤の必要性が高まり、キナーゼプロファイリングが創薬プロセスの初期段階において極めて重要なステップとなっています。がん、自己免疫疾患、心血管系疾患、中枢神経系疾患など、キナーゼに関連する疾患の適応症の増加により、これらのサービスの応用範囲が広がっています。同時に、治療薬候補の複雑化と、より深い生物学的洞察の必要性から、企業はキナーゼプロファイリングを、専門的能力、拡張可能なインフラ、規制対応可能なデータ出力を提供する専門サービスプロバイダーに委託するようになっています。ハイスループットとマルチプレックスアッセイ技術の採用は、スクリーニング効率を加速し、大規模なキナーゼライブラリーの同時評価を可能にし、それによってコストとタイムラインを削減しています。バイオインフォマティクスの統合とAI主導のモデリングにより、データの解釈と化合物の優先順位付けが強化され、プロファイリングキャンペーンの投資収益率が向上しています。キナーゼ関連研究のための政府助成金や研究助成金の増加も、外部のスクリーニングパートナーに依存する学術的プロジェクトやトランスレーショナル・プロジェクトを支援しています。さらに、特に中小規模のバイオテクノロジー企業において、研究開発活動をアウトソーシングする世界の動向が、柔軟でカスタマイズ可能なキナーゼアッセイサービスに対する需要を促進しています。規制当局が申請プロセスにおいてターゲットの検証や作用機序のデータを重視するようになったことで、早期かつ徹底したキナーゼプロファイリングの重要性が高まっています。最後に、併用療法やマルチターゲットドラッグアプローチの台頭は、相乗効果や拮抗効果を予測するためのより広範なプロファイリング努力を促しています。これらの複合的な推進力により、キナーゼスクリーニングおよびプロファイリングサービスは世界の製薬および生物医学研究エコシステムの重要な柱として確固たる地位を築きつつあります。

セグメント

タイプ（放射性同位体、均質非放射性同位体）、用途（企業、研究機関）

調査対象企業の例

  • BPS Bioscience, Inc.
  • Charles River Laboratories
  • Creative Biogene
  • Creative Enzymes
  • Crown Bioscience（JSR Life Sciences）
  • Eurofins DiscoverX
  • GenScript Biotech Corp.
  • HD Biosciences（WuXi AppTec）
  • Kinexus
  • LC Sciences
  • Luceome Biotechnologies
  • MedChemExpress（MCE）
  • Novogene
  • Pharmaron
  • Promega Corporation
  • Reaction Biology Corp.
  • Sino Biological, Inc.
  • Sygnature Discovery
  • Thermo Fisher Scientific
  • WuXi AppTec

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、企業、製品/サービス、および市場データの膨大な量を含む、世界中のドメイン専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37238

Global Kinase Screening and Profiling Services Market to Reach US$436.1 Million by 2030

The global market for Kinase Screening and Profiling Services estimated at US$357.4 Million in the year 2024, is expected to reach US$436.1 Million by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Radioisotope Method Type, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$290.9 Million by the end of the analysis period. Growth in the Homogeneous Non-Radioisotope Method Type segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.4 Million While China is Forecast to Grow at 6.2% CAGR

The Kinase Screening and Profiling Services market in the U.S. is estimated at US$97.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$86.0 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Kinase Screening and Profiling Services Market - Key Trends & Drivers Summarized

Why Are Kinase Screening and Profiling Services Gaining Momentum in Drug Discovery?

Kinase screening and profiling services have become a cornerstone of modern drug discovery, particularly in the fields of oncology, inflammation, metabolic disorders, and neurodegenerative diseases. Kinases, a large family of enzymes involved in signal transduction and cell regulation, are critical targets for therapeutic intervention due to their central role in cellular communication, growth, and apoptosis. Dysregulation of kinase activity is implicated in a wide spectrum of diseases, most notably cancers, where specific kinases act as drivers of tumor progression and resistance to therapy. As pharmaceutical and biotech companies race to develop targeted therapies, kinase profiling allows researchers to assess compound selectivity, off-target effects, and potential toxicity early in the development pipeline. High-throughput screening platforms, coupled with extensive kinase panels, enable rapid evaluation of thousands of compounds across hundreds of kinase targets, generating rich datasets that inform medicinal chemistry strategies. The demand for these services has intensified with the rise of personalized medicine, where identifying kinase-driven mutations and tailoring drug regimens accordingly can significantly improve treatment outcomes. Academic research institutions are also contributing to this momentum by collaborating with commercial service providers to validate novel kinase targets and identify potential leads for further development. The growth of kinase-focused drug pipelines and the increasing number of kinase inhibitors under investigation have created a favorable environment for service providers offering assay development, selectivity profiling, and mechanistic studies. This surge in activity is fueling continuous innovation in assay formats, detection technologies, and bioinformatics tools that underpin kinase research, making these services indispensable to competitive and accelerated drug discovery workflows.

How Is Technology Enhancing the Scope and Precision of Kinase Profiling?

Technological advancements have radically transformed the scope, accuracy, and speed of kinase screening and profiling services, making them more essential than ever in the pharmaceutical research landscape. Traditional low-throughput methods have been replaced by next-generation platforms that integrate high-throughput screening, mass spectrometry-based proteomics, and automated robotics to handle complex assay setups efficiently. These tools provide researchers with the ability to assess hundreds of kinases simultaneously under various conditions, enabling a comprehensive understanding of compound behavior across the kinome. Innovations in fluorescence polarization, time-resolved FRET, and enzyme-coupled detection techniques have improved assay sensitivity and reduced signal interference, making it easier to distinguish between active and inactive targets. Additionally, advances in cell-based kinase assays have enhanced the ability to study compounds in physiologically relevant models, capturing effects that may be missed in isolated enzyme systems. The integration of computational modeling and artificial intelligence is adding a new dimension to kinase research by predicting binding affinities, modeling inhibitor interactions, and optimizing hit-to-lead workflows. Open-access kinase databases, enriched with real-time experimental results, are further enabling researchers to benchmark new compounds against known profiles and uncover novel selectivity signatures. Service providers are leveraging cloud-based data platforms to offer clients interactive dashboards, real-time analytics, and secure data sharing, enhancing collaboration and decision-making. Customizable assay panels, target-specific profiling kits, and multiplex screening options are expanding the usability of these services across therapeutic areas. These technological improvements are not only reducing development timelines and costs but also increasing the success rate of kinase-targeted therapeutics, demonstrating the powerful synergy between innovation and drug discovery.

What Market Forces and Strategic Collaborations Are Influencing Service Providers?

The kinase screening and profiling services market is being shaped by a dynamic interplay of industry demand, collaborative research models, and evolving regulatory landscapes. As biopharmaceutical companies shift toward precision medicine and targeted therapies, there is an increasing reliance on outsourced discovery services to provide high-quality, reproducible data that accelerates compound optimization. This has led to a surge in demand for contract research organizations (CROs) and specialized service providers capable of offering end-to-end kinase assay platforms, from initial screening to in-depth mechanistic studies. Many companies are entering strategic partnerships or forming long-term alliances with academic institutions and biotech firms to co-develop kinase inhibitors, share research infrastructure, and streamline development pipelines. Public-private initiatives are also fostering kinase research, particularly in areas with unmet medical needs such as rare cancers and neurodegenerative diseases. Venture capital funding in early-stage biotech companies with kinase-focused pipelines is further stimulating demand for external profiling services that offer cost-effective, high-throughput capabilities. Additionally, the globalization of drug development has expanded the reach of service providers, who are now catering to clients across North America, Europe, and Asia-Pacific. Regulatory bodies such as the FDA and EMA are reinforcing the importance of selectivity data and mechanistic validation in investigational new drug (IND) submissions, prompting companies to invest in rigorous kinase profiling early in development. Service providers are responding by enhancing quality assurance protocols, investing in regulatory-compliant infrastructure, and expanding service portfolios to include follow-on validation studies. The convergence of these market forces is reinforcing the strategic value of kinase screening and profiling, not only as a technical service but also as a critical enabler of innovation and regulatory success.

What Is Driving Growth in the Global Kinase Screening and Profiling Services Market?

The growth in the global kinase screening and profiling services market is driven by several interconnected factors rooted in drug development strategies, technological evolution, and shifting research priorities. The expanding focus on precision therapeutics has intensified the need for selective and potent kinase inhibitors, making kinase profiling a crucial step in the early-phase drug discovery process. The increasing number of kinase-related disease indications, including cancer, autoimmune disorders, cardiovascular conditions, and central nervous system diseases, is broadening the application base for these services. At the same time, the growing complexity of therapeutic candidates and the need for deeper biological insights are prompting companies to outsource kinase profiling to expert service providers who offer specialized capabilities, scalable infrastructure, and regulatory-ready data outputs. The adoption of high-throughput and multiplex assay technologies is accelerating screening efficiency and enabling simultaneous evaluation across large kinase libraries, thereby reducing costs and timelines. Bioinformatics integration and AI-driven modeling are enhancing data interpretation and compound prioritization, increasing the return on investment in profiling campaigns. Increased government funding and research grants for kinase-related studies are also supporting academic and translational projects that rely on external screening partners. Furthermore, the global trend toward outsourcing R&D activities, especially among small and mid-sized biotech firms, is fueling demand for flexible and customizable kinase assay services. Regulatory emphasis on target validation and mechanism of action data in submission processes is reinforcing the importance of early and thorough kinase profiling. Lastly, the rise of combination therapies and multi-target drug approaches is encouraging more extensive profiling efforts to anticipate synergistic or antagonistic effects. These combined drivers are solidifying kinase screening and profiling services as a critical pillar of the global pharmaceutical and biomedical research ecosystem.

SCOPE OF STUDY:

The report analyzes the Kinase Screening and Profiling Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Radioisotope Method Type, Homogeneous Non-Radioisotope Method Type); Application (Enterprise Application, Research Institute Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • BPS Bioscience, Inc.
  • Charles River Laboratories
  • Creative Biogene
  • Creative Enzymes
  • Crown Bioscience (JSR Life Sciences)
  • Eurofins DiscoverX
  • GenScript Biotech Corp.
  • HD Biosciences (WuXi AppTec)
  • Kinexus
  • LC Sciences
  • Luceome Biotechnologies
  • MedChemExpress (MCE)
  • Novogene
  • Pharmaron
  • Promega Corporation
  • Reaction Biology Corp.
  • Sino Biological, Inc.
  • Sygnature Discovery
  • Thermo Fisher Scientific
  • WuXi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Kinase Screening and Profiling Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Kinase-Targeted Drug Discovery Throws the Spotlight on Screening and Profiling Services
    • Expanding Oncology Pipeline Propels Growth in Demand for Kinase Selectivity and Inhibition Profiling
    • Precision Medicine Trends Strengthen Business Case for Targeted Kinase Activity Mapping
    • Rise of Allosteric and Covalent Inhibitors Spurs Innovation in Specialized Kinase Assay Development
    • Biopharma Outsourcing Trends Drive Adoption of End-to-End Kinase Screening Service Models
    • Emergence of Novel Kinase Targets in Rare and Neurodegenerative Diseases Expands Service Opportunities
    • High Failure Rates in Kinase Drug Development Accelerate Demand for Early-Stage Profiling Precision
    • Advancements in High-Throughput and Multiplexed Screening Technologies Fuel Scalable Profiling Platforms
    • Integration of AI and Bioinformatics in Kinase Analysis Enhances Predictive Modeling Capabilities
    • Growing Investment in Immuno-Oncology Throws the Spotlight on Kinase Pathway Modulation Strategies
    • Increasing Adoption of CRISPR and RNAi Technologies Generates Demand for Functional Kinase Validation Services
    • Shift Toward Custom Assay Development and Multi-Target Profiling Sustains Market Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Kinase Screening and Profiling Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Kinase Screening and Profiling Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Kinase Screening and Profiling Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Radioisotope Method Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Radioisotope Method Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Radioisotope Method Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Homogeneous Non-Radioisotope Method Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Homogeneous Non-Radioisotope Method Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Homogeneous Non-Radioisotope Method Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Enterprise Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Enterprise Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Enterprise Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Institute Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Research Institute Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Research Institute Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • CHINA
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: China 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Kinase Screening and Profiling Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Kinase Screening and Profiling Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: France 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: UK 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Spain 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Russia 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Kinase Screening and Profiling Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Kinase Screening and Profiling Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Australia 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • INDIA
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: India 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: South Korea 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Kinase Screening and Profiling Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Latin America 16-Year Perspective for Kinase Screening and Profiling Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Argentina 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Brazil 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Mexico 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Kinase Screening and Profiling Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Middle East 16-Year Perspective for Kinase Screening and Profiling Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Iran 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Israel 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: UAE 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Kinase Screening and Profiling Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Kinase Screening and Profiling Services by Type - Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Africa 16-Year Perspective for Kinase Screening and Profiling Services by Type - Percentage Breakdown of Value Sales for Radioisotope Method Type and Homogeneous Non-Radioisotope Method Type for the Years 2014, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Kinase Screening and Profiling Services by Application - Enterprise Application and Research Institute Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Kinase Screening and Profiling Services by Application - Percentage Breakdown of Value Sales for Enterprise Application and Research Institute Application for the Years 2014, 2025 & 2030

IV. COMPETITION